Chronic kidney diseases can soon be detected early with the help of ACT by Zensorium, a device that is undergoing testing at the Singapore General Hospital.

Offered by the Nitto Denko Asia Technical Centre (NAT), the research and development arm of the Tokyo Stock Exchange-listed Nitto Denko, the device works by testing a patient’s urine sample for increased levels of albumin and creatinine. 

Albumin is a protein produced by the liver while creatinine is a waste product created from the wear and tear of muscles. High levels of these, correlates to a higher risk of a patient having chronic kidney disease.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook